
Celldex Therapeutics CLDX
€ 22.38
2.41%
Quartalsbericht 2025-Q3
hinzugefügt 10.11.2025
Celldex Therapeutics Langfristiger Schuldenstrom 2011-2026 | CLDX
Langfristiger Schuldenstrom Jährlich Celldex Therapeutics
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.45 M | 1.61 M | 1.44 M | 1.75 M | 1.33 M | 1.94 M | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 1.94 M | 1.33 M | 1.59 M |
Langfristiger Schuldenstrom anderer Aktien in der Pharmaeinzelhändler
| Name | Langfristiger Schuldenstrom | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Biogen
BIIB
|
86.4 M | $ 172.65 | 0.62 % | $ 25.1 B | ||
|
MorphoSys AG
MOR
|
3.63 M | - | 2.43 % | $ 254 M | ||
|
Adagene
ADAG
|
1.18 M | $ 2.38 | -4.22 % | $ 134 M | ||
|
Acorda Therapeutics
ACOR
|
1.59 M | - | -24.86 % | $ 820 K | ||
|
BioNTech SE
BNTX
|
39.5 M | $ 117.22 | 1.07 % | $ 27.2 B | ||
|
Aptorum Group Limited
APM
|
433 K | $ 0.98 | 1.35 % | $ 5.34 M | ||
|
Alterity Therapeutics Limited
ATHE
|
57.6 K | $ 3.62 | 1.91 % | $ 8.71 B | ||
|
Catalyst Biosciences
CBIO
|
210 K | $ 12.1 | -5.47 % | $ 797 M | ||
|
BioXcel Therapeutics
BTAI
|
374 K | $ 1.78 | -2.47 % | $ 4.51 M | ||
|
BioLineRx Ltd.
BLRX
|
522 K | $ 3.05 | -1.77 % | $ 908 M | ||
|
Applied Molecular Transport
AMTI
|
4.64 M | - | - | $ 10.1 M | ||
|
Ascendis Pharma A/S
ASND
|
14.2 M | $ 232.9 | -1.06 % | $ 5 B | ||
|
ARCA biopharma
ABIO
|
213 K | - | 1052.0 % | $ 415 M | ||
|
Cellectis S.A.
CLLS
|
8.38 M | $ 4.21 | -4.84 % | $ 116 M | ||
|
Acasti Pharma
ACST
|
75 K | - | 4.01 % | $ 150 M | ||
|
Arrowhead Pharmaceuticals
ARWR
|
7.29 M | $ 67.14 | 0.13 % | $ 8.98 B | ||
|
Compugen Ltd.
CGEN
|
768 K | $ 2.05 | -1.91 % | $ 184 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
43 K | $ 4.4 | -2.87 % | $ 9.57 B | ||
|
Aeterna Zentaris
AEZS
|
271 K | - | 5.93 % | $ 314 M | ||
|
AgeX Therapeutics
AGE
|
428 K | - | -10.17 % | $ 12.2 K | ||
|
Aeglea BioTherapeutics
AGLE
|
625 K | - | - | $ 1.01 B | ||
|
Akouos
AKUS
|
671 K | - | 0.23 % | $ 488 M | ||
|
Adaptimmune Therapeutics plc
ADAP
|
5.38 M | - | -15.15 % | $ 60.3 M | ||
|
Amphastar Pharmaceuticals
AMPH
|
6.8 M | $ 26.56 | 2.45 % | $ 1.29 B | ||
|
Coherus BioSciences
CHRS
|
1.42 M | $ 2.25 | 9.22 % | $ 212 M | ||
|
Amneal Pharmaceuticals
AMRX
|
224 M | $ 13.58 | 1.42 % | $ 4.2 B | ||
|
AIkido Pharma
AIKI
|
410 K | - | 1.93 % | $ 17.4 M | ||
|
Albireo Pharma
ALBO
|
3.08 M | - | -0.23 % | $ 916 M | ||
|
CureVac N.V.
CVAC
|
3.47 M | - | - | $ 867 M | ||
|
Aptose Biosciences
APTO
|
428 K | - | -45.71 % | $ 1.2 M | ||
|
Acer Therapeutics
ACER
|
104 K | - | 2.71 % | $ 14 M | ||
|
Aravive
ARAV
|
2.2 M | - | -13.39 % | $ 1.45 M | ||
|
Alpine Immune Sciences
ALPN
|
756 K | - | - | $ 2.17 B | ||
|
AlloVir
ALVR
|
10.8 M | - | 4.14 % | $ 49.1 M | ||
|
Athira Pharma
ATHA
|
414 K | - | - | $ 269 M | ||
|
Ampio Pharmaceuticals
AMPE
|
274 K | - | -11.43 % | $ 502 K | ||
|
AVROBIO
AVRO
|
878 K | - | 1083.1 % | $ 745 M | ||
|
Ayala Pharmaceuticals
AYLA
|
419 K | - | - | $ 7.46 M | ||
|
Aytu BioScience
AYTU
|
137 K | $ 2.75 | 1.84 % | $ 17.3 M | ||
|
AstraZeneca PLC
AZN
|
339 M | $ 94.2 | 1.34 % | $ 96.9 B | ||
|
Brickell Biotech
BBI
|
49 K | - | -5.38 % | $ 6.06 M |